Congenital heart disease (CHD) affects approximately 1% of live births. Thanks to surgical advancements, infants born with ...
Jones Trading initiated coverage on ProQR Therapeutics N.V. (NASDAQ:PRQR) with a Buy rating and set a price target of $11.00, representing significant upside from the current price of $2.19. The ...